• About us
• Contact

Advertisement

Product › Details

vaccine, RSV

	Next higher product group	vaccine

Record changed: 2023-07-10

Advertisement

More documents for vaccine, RSV

• [1] Bavarian Nordic A/S. (3/21/22). "Press Release: Bavarian Nordic Announces License and Supply Agreement with Nuance Pharma on the Development and Commercialization of Respiratory Syncytial Virus (RSV) Vaccine for Adults in China and Selected Asian Markets...
• [2] Bavarian Nordic A/S. (12/6/21). "Press Release: Bavarian Nordic Commits to Initiating Phase 3 Trial of RSV Vaccine Candidate and to Strengthening its Capital Base". Copenhagen....
• [3] Virometix AG. (3/12/20). "Press Release: Virometix Announces Initiation of Phase 1 Clinical Trial with Its V-306 Vaccine Candidate". Schlieren....
• [4] CureVac AG. (1/8/19). "Press Release: CureVac Announces U.S. Patent Grant for mRNA Vaccination of Infants against RSV". Tübingen & Boston, MA....
• [5] Bavarian Nordic A/S. (5/24/18). "Press Release: Bavarian Nordic Announces Interim Results for the First Three Months of 2018". Copenhagen....
• [6] Bavarian Nordic A/S. (3/6/18). "Press Release: Bavarian Nordic Announces Additional Positive Data from a Phase 2 Study of its Universal RSV Vaccine". Copenhagen....
• [7] Bavarian Nordic A/S. (9/21/17). "Press Release: Bavarian Nordic Provides Update on Its Universal RSV Vaccine". Copenhagen....
• [8] Bavarian Nordic A/S. (6/27/17). "Press Release: Bavarian Nordic Announces Positive Data from Ongoing Phase 2 Study Investigating a Universal RSV Vaccine". Copenhagen....
• [9] CureVac AG. (6/13/17). "Press Release: CureVac Extends Global Intellectual Property Estate for Prophylactic mRNA Vaccines". Tübingen....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2023. Made in Germany.